PPTA Twitter

PlasmaProteins Throughout 2019, @PlasmaProteins will advocate across the healthcare industry to ensure those living with #rarediseases receive access to the #plasmaprotein therapies they need. bit.ly/2JFf1Db
About 8 hours ago.
PlasmaProteins Typically, it takes about 7-12 months to manufacture #plasmaprotein therapies, which includes the steps to ensure quality and safety of the produced PPTs. Learn more about the plasma manufacturing process: bit.ly/2ytTQCI twitter.com/PlasmaProteins/status/1084906790272274432
2 days ago.

Plasma Protein Therapeutics Association

The Plasma Protein Therapeutics Association (PPTA) represents the private sector manufacturers of plasma-derived and recombinant analog therapies, collectively known as plasma protein therapies and the collectors of source plasma used for fractionation. These therapies are used by small patient populations worldwide to treat a variety of rare diseases and serious medical conditions.

Erica XLA

PPTA works globally to:

    • Advocate for access to and affordability of therapies for patients
    • Engage in constructive dialogue with regulatory agencies
    • Collaborate with patient advocacy organizations

PPTA also administers standards and programs that help ensure the quality and safety of plasma collection and manufacturing and protect both donors and patients.

Copyright © 2018 PPTA. All rights reserved. (202) 789-3100